Is pregabalin (lyrica) safe for treating sciatica during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pregabalin Should Not Be Used for Sciatica During Pregnancy

Pregabalin is not recommended for treating sciatica during pregnancy due to potential risks to the fetus, including skeletal malformations and developmental toxicity observed in animal studies. 1

Safety Concerns with Pregabalin in Pregnancy

Pregabalin's FDA label clearly indicates significant concerns:

  • Animal reproduction studies show increased incidences of fetal structural abnormalities, skeletal malformations, retarded ossification, and decreased fetal body weight 1
  • These effects were observed at doses producing plasma pregabalin exposures greater than or equal to 16 times human exposure at the maximum recommended dose 1
  • The FDA label states that "it is not known if these problems can happen in people who take pregabalin" but warns that "pregabalin may harm your unborn baby" 1

While limited human data exists, the available evidence is insufficient to establish safety:

  • A 2018 review of four studies on pregabalin use in pregnancy found inconsistent results regarding malformation rates (ranging from 3.3% to 7.7%) 2
  • The largest study (n=477) found no increased risk of major malformations, but all analyses were underpowered 2

Recommended Alternatives for Sciatica in Pregnancy

For managing sciatica during pregnancy, a stepwise approach is recommended:

First-Line Options:

  • Non-pharmacological interventions: physical therapy, exercise, proper postural hygiene, rest periods, heat or cold therapy, and acupuncture 3
  • Acetaminophen (maximum daily dose 3000-4000 mg) is the first-line medication recommended by the American College of Obstetricians and Gynecologists 3

Second-Line Options (Second Trimester Only):

  • NSAIDs may be considered for short-term use (7-10 days) during the second trimester only 3
  • NSAIDs are contraindicated in the first and third trimesters due to risks of congenital malformations and premature closure of the ductus arteriosus 4, 3

Third-Line Options:

  • For severe, refractory pain: referral to a specialist for evaluation 3
  • Low-dose opioids may be considered in extreme cases only when other treatments fail, with close monitoring due to the risk of dependence 3

Efficacy Considerations

It's worth noting that even in non-pregnant patients, pregabalin's efficacy for sciatica is questionable:

  • A 2017 randomized controlled trial found that pregabalin did not significantly reduce the intensity of leg pain associated with sciatica compared to placebo over 8 weeks 5
  • A 2019 study comparing pregabalin and gabapentin for chronic sciatica found that while both were efficacious, gabapentin was superior with fewer and less severe adverse events 6

Conclusion

Given the potential risks to the fetus demonstrated in animal studies, the lack of robust safety data in human pregnancies, and the availability of safer alternatives, pregabalin should not be used for treating sciatica during pregnancy. The risk-benefit ratio does not favor its use in this population when safer options exist.

If medication is needed for sciatica during pregnancy, acetaminophen should be tried first, followed by short-term NSAIDs in the second trimester only if necessary, with specialist consultation for refractory cases.

References

Research

Safety of Pregabalin in Pregnancy.

The Journal of clinical psychiatry, 2018

Guideline

Management of Sciatica Pain During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Trial of Pregabalin for Acute and Chronic Sciatica.

The New England journal of medicine, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.